StonvexLoading…
StonvexStonvexStonvexCore line items from MITK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $51.71M | $99.08M | $44.24M | $179.69M | $134.91M |
Operating Income | Not available | $18.99M | $5.44M | $16.79M | $12.10M |
Net Income | Not available | $12.31M | $2.77M | $8.80M | $6.94M |
EPS (Diluted) | $0.29 | $0.25 | $0.06 | $0.19 | $0.15 |
Total Assets | Not available | $356.94M | $446.45M | $459.11M | $446.71M |
Total Liabilities | Not available | $117.47M | $212.80M | $218.85M | $209.12M |
Cash & Equivalents | Not available | $69.19M | $175.12M | $154.15M | $127.12M |
Free Cash Flow OCF − CapEx | Not available | $4.09M | $6.59M | $54.19M | $34.98M |
Shares Outstanding | Not available | 44.86M | 45.28M | 45.64M | 45.62M |